• Users Online: 840
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2022  |  Volume : 15  |  Issue : 2  |  Page : 59-65

Pulmonary mucormycosis: An anaesthesiologist's perspective


Department of Anesthesia and Pain Management, Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra, India

Correspondence Address:
Ankit Ashok Gupta
467/75 Hussainbhai Mansion, Maulana Azad Road, 3rd Floor, Null Bazaar, Mumbai - 400 003, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/hmj.hmj_26_22

Rights and Permissions

Introduction: As a frontline warrior, every anesthesiologist is fighting the coronavirus 2019 (COVID-19) pandemic to save lives, but at the same time, post-COVID sepsis has emerged as a serious challenge opening a new battlefield for corona warriors. In recent times, mucormycosis, a rare opportunistic fungal infection, has emerged as a serious and life-threatening disease that is spreading rapidly, leading to tissue infarction and necrosis in post-COVID patients; hence, quick recognition of this potentially lethal disease and early treatment is of paramount importance in reducing the mortality rate. Methods: The aim of this review article was to summarise the literature on anesthestic management of pulmonary mucormycosis (PM) patients undergoing thoracotomy surgery. Searches had been conducted in Google Scholar, Wiley online library, National Library of Medicine, PubMed, Scopus, Excerpta Medica Database and Cochrane Library using the following keywords: lung, mucormycosis, anaesthesia, presurgical, intraoperative, postsurgical and their permutations. Results: The true frequency of mucormycosis in India is still unknown; however, it is found to be consequentially more than in Western nations. PM has a high mortality rate, which is attributable in part to its locally aggressive nature and in part to the underlying risk factors; however, this rate has improved over time due to advancements in diagnostic techniques. Conclusion: Management of PM must be approached with a multifaceted, assertive plan. Early identification of infection, reversal of the prevailing risk factors, surgical elimination of contaminated tissue and medical management by antimycotic agents are the four critical steps in the management of mucormycosis. The key to a successful operation was a thorough pre-operative assessment, proper pre-operative preparation and much clinical surgical expertise.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed696    
    Printed0    
    Emailed0    
    PDF Downloaded113    
    Comments [Add]    

Recommend this journal